USC Institute of Urology, Keck School of Medicine, University of Southern California, 1441 Eastlake Ave, Los Angeles, CA, 90089, USA.
Department of Anesthesiology, Keck School of Medicine, University of Southern California, 1975 Zonal Ave, Los Angeles, CA, 90033, USA.
J Robot Surg. 2022 Dec;16(6):1383-1389. doi: 10.1007/s11701-022-01379-9. Epub 2022 Feb 10.
Enhanced Recovery After Surgery (ERAS) protocols have been developed in several fields to reduce hospitalization lengths and overall costs. There have also been developments in multimodal analgesia methods to curtail opioid usage after surgery. Herein, we present the results of our initiation of an ERAS protocol for robotic-assisted laparoscopic partial and radical nephrectomies, employing a quadratus lumborum (QL) regional anesthetic block. We retrospectively reviewed 614 patients in our Institutional Review Board approved database who underwent robotic-assisted laparoscopic partial or radical nephrectomies from January 2017 to February 2020. An ERAS protocol utilizing multimodal analgesia (acetaminophen and gabapentin) and a QL block was developed and introduced in February 2019. We then compared the opioid consumption and perioperative outcomes of patients before and after ERAS protocol initiation. 192 ERAS patients (February 2019 to February 2020) were compared to 422 non-ERAS patients (January 2017 to January 2019). Baseline characteristics and the proportion of preoperative opioids users were similar between the two groups. There were no statistically significant differences in surgery length, hospitalization length, or complication rates. There were statistically significant differences in our primary endpoint, opioid consumption, on post-operative days 0 (p < 0.001), 1 (p < 0.001), and 2 (p < 0.001). The total opioid requirements over the course of admission were lower in the ERAS group compared to the non-ERAS group (p = 0.03). The initiation of an ERAS protocol employing multimodal analgesia and a QL block, for patients undergoing robotic-assisted laparoscopic partial or radical nephrectomies, can decrease opioid requirements without compromising perioperative outcomes.
加速康复外科(ERAS)方案已在多个领域制定,以减少住院时间和总体成本。在多模式镇痛方法方面也有了发展,可以减少手术后阿片类药物的使用。在此,我们报告了我们在机器人辅助腹腔镜部分和根治性肾切除术开始使用竖脊肌(QL)区域麻醉阻滞的 ERAS 方案的结果。我们回顾性地审查了我们机构审查委员会批准的数据库中 614 例患者的资料,这些患者于 2017 年 1 月至 2020 年 2 月接受了机器人辅助腹腔镜部分或根治性肾切除术。制定并推出了使用多模式镇痛(对乙酰氨基酚和加巴喷丁)和 QL 阻滞的 ERAS 方案,然后比较了 ERAS 方案启动前后患者的阿片类药物消耗和围手术期结果。将 192 例 ERAS 患者(2019 年 2 月至 2020 年 2 月)与 422 例非 ERAS 患者(2017 年 1 月至 2019 年 1 月)进行比较。两组患者的基线特征和术前阿片类药物使用者的比例相似。手术时间、住院时间或并发症发生率无统计学差异。在我们的主要终点,术后第 0 天(p<0.001)、第 1 天(p<0.001)和第 2 天(p<0.001)的阿片类药物消耗方面有统计学显著差异。与非 ERAS 组相比,ERAS 组在住院期间的总阿片类药物需求较低(p=0.03)。对于接受机器人辅助腹腔镜部分或根治性肾切除术的患者,使用多模式镇痛和 QL 阻滞的 ERAS 方案可以减少阿片类药物的需求,而不会影响围手术期结果。